SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus

Aventus ($AVT.X) is trending on Stocktwits, with community members highlighting its low market cap and Coinbase listing as potential catalysts for a price surge. Some users are pointing to impressive company updates and partnerships as reasons for optimism, while others are focused on technical indicators and breakout potential.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending upwards, driven by a mix of potential Q3 delivery beats, optimism around future growth areas like robotics and energy storage, and anticipation of upcoming Fed rate cuts. Community discussions revolve around the stock's momentum, potential short squeezes, and debate over Elon Musk's influence on the company.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as discussions revolve around lobbying efforts and a potential meeting with President Trump amidst an ongoing DOJ probe, with community members debating the impact of these factors. Some believe a resolution to the probe is near, while others speculate about the potential for increased regulatory challenges. Retail traders remain bullish on the stock's long-term prospects.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as community members discuss potential market manipulation and await key economic data releases this week. There's concern about a possible correction, particularly with high margin leverage and an inverted yield curve, but also some bullish sentiment fueled by potential Fed rate cuts. Discussion also revolves around individual stock performance within the Dow, like Microsoft, and the potential impact of political factors.

Assemble’s AI agent, News3(NS3), was developed with the goal of revolutionizing Web 3.0 journalism. NS3 delivers crypto and global economic trends quickly and clearly, and leverages advanced AI reasoning capabilities to analyze these trends, enabling market participants to make data-driven decisions. In particular, NS3 utilizes OpenAI’s latest reasoning model as its core engine to analyze crypto and economic trends, providing a range of insights including market psychology, past case analysis, future predictions, ripple effects, and investment strategies in 12 languages.

Assemble Protocol

Assemble Protocol ($ASM.X) is trending as traders discuss potential pumps and dumps, with some pointing to activity from Asian whale wallets. The community is closely watching technical indicators and anticipating a breakout, while others remain skeptical due to past volatility. Conversations mention a potential listing on Binance and the broader context of AI-related tokens.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT.X) is surging, driven by a recent listing on major exchanges like Binance, sparking significant buying pressure and high trading volume. The community is buzzing with excitement, anticipating further price increases and drawing comparisons to other successful tokens. Many believe this is just the beginning, with some speculating about substantial gains in the near future.

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending as the community discusses its potential correlation with Ethereum's price movements and anticipation surrounding possible rate cuts, with some speculating about a significant boost from Tom Lee's future announcements. Community members are weighing the stock's premium and potential arbitrage opportunities, while others are analyzing technical indicators for potential breakouts. The discussion also includes the company's growing Ethereum treasury and its strategic direction as a crypto hedge fund.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

The community is buzzing about aTyr Pharma as they anticipate the release of Phase 3 trial data for Efzofitimod, a drug targeting pulmonary sarcoidosis; many expect the data drop sometime next week. Community talking points range from potential FDA approval and buyout scenarios to skepticism fueled by bearish perspectives. Some traders are strategizing around options, with implied volatility high as the community speculates on whether the results will trigger a short squeeze or a significant price drop.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending as traders discuss the company's recent $20 million investment agreement and upcoming presentation at a virtual investor summit, anticipating potential catalysts and news. Community members are weighing the potential for a short squeeze given the low float and upcoming events, while others caution about potential dilution and past reverse splits. The company's glucose monitoring technology and potential competition with larger players like Dexcom and Abbott are also key discussion points.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as investors discuss the company's contracts and transparency, with some expressing skepticism over the lack of detailed financial disclosures and SEC filings. Community members are weighing the potential impact of upcoming events, including Climate Week, and a possible presentation alongside NVDA. Some investors remain bullish, drawing comparisons to PLTR's early growth and anticipating significant gains from international contracts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MYNA has reached a settlement with investors over claims that it misled them about production delays, component shortages, and its ability to meet 2024 financial guidance. 
 
Who’s eligible? 
Anyone who purchased $MOYFF shares between June 20, 2024, and January 3, 2025. 
 
Do I need to sell my shares to qualify? 
No — you are eligible whether you sold your shares or still hold them. 
 
How much is the payout? 
The payout per share is $0.137 — but if only ~25% of eligible investors file, the effective payout could increase to $0.55 per share. 
 
Can I still file? 
Yes — claims are currently being accepted. 
 
When do payouts happen? 
Typically within 8–12 months after court approval of the settlement. 
 
To file your claim: https://11th.com/cases/mynaric-investor-suit?utm_source=stocktwits&amp;utm_medium=referral&amp;utm_campaign=faq&amp;utm_content=08272025_1

Mynaric has reached a settlement with $MYNA investors over claims that it misled them about production delays, component shortages, and its ability to meet f...

11th.com

Mynaric ($MYNA) Investor Settlement

StockTwits Web

Mynaric ADS

Mynaric AG

 has reached a settlement with investors over claims that it misled them about production delays, component shortages, and its ability to meet 2024 financial guidance. 
 
Who’s eligible? 
Anyone who purchased 

 shares between June 20, 2024, and January 3, 2025. 
 
Do I need to sell my shares to qualify? 
No — you are eligible whether you sold your shares or still hold them. 
 
How much is the payout? 
The payout per share is $0.137 — but if only ~25% of eligible investors file, the effective payout could increase to $0.55 per share. 
 
Can I still file? 
Yes — claims are currently being accepted. 
 
When do payouts happen? 
Typically within 8–12 months after court approval of the settlement. 
 
To file your claim: 